Tell us about your project
Contact us to discuss how we can help you achieve your research goals
Clinical Panels

NovoFocus? NSCLC 2.0

NovoFocus? NSCLC 2.0 Test is a next generation sequencing (NGS)-based assay that analyzes 47 genes related to Non-Small Cell Lung Cancer (NSCLC) for clinically important alterations at the DNA level. These genes are known to be relevant for the diagnosis and/or treatment of various NSCLC according to National Comprehensive Cancer Network (NCCN) guideline and the medical literature.

Parameters

NovoFocus? NSCLC 2.0
Cancer Type Non-Small Cell Lung Cancer
Sample Type FFPE Blood /
Plasma (Extracted DNA)
Turnaround Time 14 Calendar Days
Highlights
Comprehensive Results

NovoFocus? NSCLC 2.0 interrogates the complete coding region of 47 genes and introns of 9 genes. It can detect all four types of genomic abnormalities (SNV, InDel, CNV and fusion) and provide targeted therapy options. Besides, it analyzes pharmacogenomics and provides chemotherapy options.

Reliable Performance

Comprehensive analytical validation has been completed and the test includes rigorous quality control measures.

Competitive Price

With leading-edge sequencing solutions and superior process efficiency, Novogene offers highly competitive prices for all our service.

Who Benefits from NovoFocus? NSCLC 2.0?

NovoFocus? NSCLC 2.0 is suitable for all NSCLC patients, especially for the following:

  • Patients newly diagnosed with Non-Small Cell Lung Cancer (NSCLC)
  • NSCLC patients with drug resistance to multiple types of chemotherapy
  • NSCLC patients planning to use targeted therapy
  • NSCLC patients who are treated with chemotherapies and would like to know the efficacy and toxicity of these drugs

Workflow

What Clinical Information Does NovoFocus? NSCLC 2.0 Provide?

Provides the information regarding relevant biomarkers and genomic alterations to help match patients to targeted therapies.

Provides the SNP information related to efficacy and toxicity of chemotherapies.

Gene List

47 genes on targeted therapy
ABCG2 AKT1 ALK ATR AXL BRAF C8orf34 CCND1 CDK4
CDK6 DDR2 EGFR ERBB2 ERCC1 FGFR1 FGFR2 FGFR3 GNA11
GNAQ GSTP1 HRAS JAK1 JAK2 JAK3 KDR KIT KRAS
MAP2K1 MAP2K2 MET MTHFR NRAS NTRK1 NTRK2 NTRK3 PDGFRA
PIK3CA PTEN RET ROS1 SMO STK11 TP53 TSC1 UGT1A1
XPC XRCC1

9 genes on chemotherapy
ABCG2 C8orf34 ERCC1 GSTP1 MTHFR TP53 UGT1A1 XPC XRCC1
四川快乐十二选五最新开奖